WASHINGTON, March 6, 2017 /PRNewswire/ -- Vanda
Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA) today announced that it
will participate at the following upcoming investor conferences in
March 2017.
The Cowen and Company 37th Annual Healthcare
Conference in Boston on
Tuesday, March 7, 2017. A corporate
presentation is scheduled for 8:00 a.m.
Eastern Time.
The Oppenheimer 27th Annual Healthcare Conference in
New York City on Tuesday, March 21, 2017. A corporate presentation
is scheduled for 10:20 a.m. Eastern
Time.
The corporate presentations given at the Cowen and Oppenheimer
conferences will be available live on Vanda's corporate website,
where they also will be archived for 30 days. To access the
presentations, go to Vanda's website at www.vandapharma.com and
click on the Presentations tab on the Investor Relations page.
Please connect to the website several minutes prior to the start of
the live presentations.
About Vanda Pharmaceuticals Inc.
Vanda is a global biopharmaceutical company focused on the
development and commercialization of innovative therapies to
address high unmet medical needs and improve the lives of patients.
For more on Vanda, please visit www.vandapharma.com.
Company Contact:
Jim
Kelly
Executive Vice President and Chief Financial Officer
Vanda Pharmaceuticals Inc.
(202) 734-3428
jim.kelly@vandapharma.com
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/vanda-pharmaceuticals-announces-participation-at-march-2017-investor-conferences-300418636.html
SOURCE Vanda Pharmaceuticals Inc.